All the Active Ingredient Drugs
COBENFY
Bristol Myers Squibb (Israel) Ltd.
COBENFY
Anticholinergic agent. Trospium Chloride 20 mg, 30 mg, xanomeline 50 mg, 100 mg, 125 mg. Caps 56/60 X 50 +20 mg/100+20 mg/ 125+30 mg
Start. dosage is one 50 mg/20 mg caps, orally twice daily for at least 2 d. • Incr. to one 100 mg/20 mg caps. twice daily for at least 5 d. • Dosage may be incr. to one 125 mg/30 mg caps. twice daily based on tolerab. and response • Max. dosage is 125 mg/30 mg orally twice daily.
Tmt of schizophrenia in adults.
C/I: Hypersens.: angioedema has been reported/ urinary retent. /moder. (Child-Pugh Class B) or sev. (Child-Pugh Class C) hep. impairm./ gastric retent./ untreated narrow-angle glaucoma